Back

Agreement between four high-sensitivity cardiac troponin assays and non-invasive testing, clinical and quality of care outcomes based on the 2020 ESC guidelines: results from the ROMICAT II trial

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Triage of acute coronary syndromes Biomarkers ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Julia Karady

Massachusetts General Hospital, Boston (United States of America)

4 More presentations in this session

Presentation thumbnail
Shedding light on the grey zone: characterisation and predictors of poor outcome in patients with suspected myocardial infarction triaged to the observe zone
Doctor T. Hartikainen (Bad Krozingen, DE)
Abstract Slides
Presentation thumbnail
Age and the European Society of Cardiology 0/1-hour high sensitivity troponin T algorithm for the evaluation of patients with possible acute myocardial infarction: results from the STOP-CP study
Professor B. Allen (Gainesville, US)
Abstract Slides
Presentation thumbnail
Validation of a rapid diagnostic algorithm for diagnosis of myocardial infarction using a high-sensitivity cardiac troponin assay
Doctor J. Lehmacher (Hamburg, DE)
Abstract Slides
Presentation thumbnail
Impact of patient selection on performance of an early rule-out pathway for myocardial infarction: from research to the real world
Doctor A. Bularga (Edinburgh, GB)
Abstract Slides

Access the full session

Session thumbnail
Triage of acute coronary syndromes

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources